NCT00938951

Brief Summary

The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2009

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2009

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2009

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 14, 2009

Completed
Last Updated

February 9, 2012

Status Verified

February 1, 2012

Enrollment Period

1 month

First QC Date

July 13, 2009

Last Update Submit

February 8, 2012

Conditions

Dry Eye SymptomsVisual Performance

Keywords

Dry EyeVisual Performance

Outcome Measures

Primary Outcomes (1)

  • Effectiveness of eye drop basd on athlete's opinion/experience during a one hour practice session

    60 minutes post-dosing with test article

Study Arms (1)

Systane® Ultra

EXPERIMENTAL

Systane® Ultra

Other: Systane® Ultra

Interventions

Systane® UltraOTHER

Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3%

Systane® Ultra

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Player/ Coach must answer "Yes" to the survey eligibility question.
  • Player/Coach must voluntarily agree to participate in survey

You may not qualify if:

  • None.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Dry Eye Syndromes

Condition Hierarchy (Ancestors)

Lacrimal Apparatus DiseasesEye Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2009

First Posted

July 14, 2009

Study Start

June 1, 2009

Primary Completion

July 1, 2009

Last Updated

February 9, 2012

Record last verified: 2012-02